Untreated central nervous system (CNS) metastases or CNS metastases that have progressed
Untreated or active central nervous system metastases
Symptomatic, untreated, or actively progressing central nervous system (CNS) metastases;
Active or untreated central nervous system (CNS) metastases
Symptomatic and/or untreated central nervous system metastases
Primary central nervous system (CNS) malignancy, or untreated/active CNS metastases
Participants with known untreated brain or other central nervous system metastases are excluded
Any untreated central nervous system (CNS) lesion.
Active or untreated central nervous system (CNS) metastases
Symptomatic or untreated central nervous system (CNS) metastases
Patients with untreated central nervous system metastases
Presence of symptomatic or untreated central nervous system (CNS) metastases
Symptomatic and/or untreated central nervous system metastases
Untreated central nervous system (CNS) metastases
Untreated, symptomatic Central nervous system (CNS) metastases
Known, current central nervous system disease involvement or untreated brain metastases
Untreated central nervous system (CNS) metastases
Active or untreated central nervous system (CNS) metastases Exclusions Related to Cardiovascular Disease
Symptomatic, untreated, or actively progressing central nervous system (CNS) metastases.
Symptomatic, untreated, or actively progressing central nervous system (CNS) metastases
Active, untreated central nervous system (CNS) metastases
Patients with known brain metastases, active infection, or untreated central nervous system (CNS) leukemia
Untreated or active central nervous system metastases - Ongoing or recent (within 5 years) evidence of significant autoimmune disease
Untreated or progressive central nervous system leukemia
Patients with symptomatic, untreated central nervous system (CNS) metastases are not eligible
Patients with untreated brain metastases/central nervous system (CNS) disease will be excluded
Symptomatic untreated metastases in the central nervous system
Active or untreated central nervous system (CNS) metastases
Active, untreated central nervous system metastases.
Central nervous system metastases that are untreated or symptomatic, or require radiation, surgery, or continued steroid therapy to control symptoms within 14 days of study entry.
Subjects with symptomatic, untreated metastases to the central nervous system (CNS) at the time of screening.
Known untreated central nervous system (CNS) metastases; leptomeningeal disease will be an absolute exclusion criterion due to limited life expectancy
Symptomatic or untreated central nervous system (CNS) metastases
Untreated brain metastases or neurologically unstable central nervous system (CNS) metastases
Active, untreated central nervous system metastases.
Untreated central nervous system (CNS) metastases or CNS metastases that have progressed
Untreated or symptomatic central nervous system (CNS) metastases
known central nervous system (CNS) metastases that are untreated, symptomatic, or require steroids to control symptoms
Known active or untreated central nervous system (CNS) metastases. - Pregnant, planning to become pregnant within 6 months of treatment, or nursing.
Primary central nervous system (CNS) malignancy, or untreated/active CNS metastases
Subject has symptomatic and untreated central nervous system (CNS) disease
Known and untreated brain metastases. Patients with primary CNS (central nervous system) malignancies are excluded.
Known and untreated, or active central nervous system (CNS) metastases (progressing or requiring treatment)
Symptomatic, untreated, or actively progressing central nervous system (CNS) metastases
Primary central nervous system (CNS) malignancy, or untreated/active CNS metastases
Participant has untreated central nervous system (CNS) metastases.
Untreated or active/progressing Central Nervous system (CNS) metastases
Known untreated or active central nervous system (CNS) metastases
Patients with untreated or symptomatic central nervous system (CNS) metastases
Untreated or symptomatic central nervous system metastases.
Symptomatic and/or untreated central nervous system metastases
Known, current central nervous system disease involvement or untreated brain metastases
Untreated or symptomatic central nervous system (CNS) metastases
Untreated central nervous system metastatic disease l
Untreated central nervous system (CNS) metastases
Known active or untreated central nervous system (CNS) metastases
Symptomatic, untreated, or actively progressing central nervous system (CNS) metastases
Patients with untreated central nervous system (CNS) or epidural tumor
Any untreated central nervous system (CNS) lesion
Presence of untreated/active central nervous system (CNS) metastases
Symptomatic or untreated central nervous system (CNS) metastases requiring concurrent treatment
Has active or untreated brain or central nervous system metastases.
Untreated central nervous system (CNS) metastases or CNS metastases that have progressed after completion of radiotherapy.
Active, untreated central nervous system metastases.
Active, untreated central nervous system metastases.
Active or untreated central nervous system (CNS) metastases
Active or untreated central nervous system (CNS) lesions
Untreated central nervous system (CNS) metastatic disease
Presence of clinically apparent untreated central nervous system metastases.
Untreated brain or central nervous system (CNS) metastases
Untreated or active central nervous system (CNS) metastases. Participants with a history of treated CNS metastases may be eligible
Untreated central nervous system metastases
Active or untreated central nervous system (CNS) metastases
Active or untreated central nervous system (CNS) metastases
Patients with untreated central nervous system metastases or local treatment of brain metastases
Symptomatic and/or untreated central nervous system metastases
Untreated or active central nervous system (CNS) metastases.
Untreated central nervous system metastases
Untreated/active central nervous system (CNS) metastases (progressing or requiring anticonvulsants or corticosteroids for symptomatic control)
Untreated or active brain metastases or central nervous system cancer, as defined per protocol
Untreated or active cerebral nervous system metastases
Known untreated or active central nervous system (CNS) metastases
Untreated or active central nervous system (CNS) metastases
Primary central nervous system (CNS) malignancy or untreated/active CNS metastases
Untreated central nervous system (CNS) metastases.
Central nervous system (CNS) disease that is untreated, symptomatic, or requires therapy to control symptoms.
Known and untreated, or active central nervous system metastases
Known primary central nervous system (CNS) malignancy or untreated or active CNS metastases
Subjects with untreated Central nervous system (CNS) metastases are excluded
Symptomatic, untreated or unstable central nervous system or leptomeningeal metastases
Active, untreated central nervous system metastases.
Criteria 6, Active or untreated central nervous system (CNS) metastases per CT or MRI evaluation during screening